Evolva starts commercial resveratrol production

30-May-2014 - Switzerland

Evolva Holding SA  announced the start of commercial production of its resveratrol ingredient. Evolva has succeeded in optimising and scaling the fermentation process, resulting in competitive production costs that allow a commercial launch. Evolva’s resveratrol is high-purity (>98% pure trans-Resveratrol), with a controlled and reliable supply chain, produced from natural and sustainable feedstocks. It is the only resveratrol product made by brewing.

Evolva has appointed a contract manufacturer in North America to produce commercial batches of resveratrol and expects to receive first deliveries in Q3 2014. Work on further reducing production costs will continue post-launch. Discussions with a global network of distributors are ongoing to accelerate sales post-launch.

Other news from the department manufacturing

More news from our other portals

All FT-IR spectrometer manufacturers at a glance